Frontlight ResearchEarly access
Trial site
Centrum Medyczne Damiana Holding Sp. z o.o.
- 3running trials
- 1closed trial
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 33 trials
- Phase 21 trial
- Status
- Active, not recruiting2 trials
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Daiichi Sankyo1 trial
- Kartos Therapeutics Inc.1 trial
- Merus B.V.1 trial
- Pfizer1 trial
Running trials
Recruiting
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis
Active, not recruiting
Active, not recruiting
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myeloproliferative neoplasms1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026